• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Exclusive

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

HealthCoronavirus

Why your wait time between COVID vaccine doses may be different than your neighbor’s

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
April 3, 2021, 9:30 AM ET

COVID-19 vaccines come with different waiting times, depending on the exact product you’re getting—whether the Pfizer/BioNTech, Moderna, or Johnson & Johnson vaccines (or, in the case of nations outside the U.S., AstraZeneca’s shot)—and on which country or locale you’re in.

That can breed some confusion. Do you have to wait three weeks or four weeks between doses? How long after your doses are you truly immune? How many shots do you even have to get, depending on which vaccine you’re getting? And why are there differences and irregularities across nations on the timing between shots?

Pfizer/BioNTech

Pfizer and BioNTech’s highly effective COVID vaccine is of the mRNA variety, as is Moderna’s. These are the first products using a so-called messenger RNA platform to be rolled out to wide swaths of the public.

Vaccines are designed to get your body to replicate large numbers of antigens (the biological materials which can induce an immune response to an unknown pathogen) over time. With traditional vaccines, that usually involves injecting dead or weakened versions of the pathogen into your body, to kickstart the immune response.

But mRNA vaccines essentially take the process a step back: They deliver a set of instructions to your own cells, training those cells to generate an immune response. In the case of COVID, that response focuses on the coronavirus’s most vulnerable element, the so-called spike protein that it uses to hook on to your cells.

For maximal effectiveness, you require two doses of these vaccines, although there is evidence that even one dose of the Pfizer or Moderna vaccines provides significant protection. It also takes about two weeks after your final dose before your immune system has produced enough antibodies to be protective to yourself and others.

For the Pfizer COVID vaccine, you’re supposed to wait three weeks between the first and second dose, meaning the entire process, from first dose to immunity, lasts about five weeks. (Note: Even after that, public health experts urge vaccinated people to keep wearing masks and socially distancing in public, and following basic public health precautions, since variant coronavirus strains are a growing problem.)

Moderna

Although Moderna’s COVID vaccine is based on the same underlying mRNA approach as Pfizer’s, its timeline is a bit different. Rather than three weeks, the dosage schedule is four weeks between the first and second shot for the Moderna vaccine. That’s because while the technologies are similar, the vaccines are still comprised of different biological elements.

But that’s not the whole story, which highlights the evolving nature of our understanding of these brand new vaccines.

“The recommended interval between doses is 21 days for Pfizer-BioNTech and 28 days for Moderna; however, up to 42 days between doses is permissible when a delay is unavoidable,” writes the Centers for Disease Control (CDC). Longer waits have taken place in some jurisdictions where supplies for second doses were scarce, including in Pennsylvania earlier this year.

That means that, based on availability, it could take up to eight weeks to receive both of your vaccine doses and then give your body two weeks’ time to develop the coronavirus antibodies.

Johnson & Johnson

Johnson & Johnson’s COVID vaccine is of the single-shot variety. It’s still recommended to wait two weeks after the injection for antibodies to build up.

The topline efficacy number for J&J’s vaccine isn’t as impressive as the Pfizer and Moderna ones, but it is still remarkably effective and more convenient since it only requires a single dose.

The company also says that it’s working on developing booster shots (as are Pfizer and Moderna) to tackle evolving strains of the coronavirus should they become a problem in the future. The same two-week timeline between getting a J&J shot and building up antibodies will likely still be the recommendation.

AstraZeneca

AstraZeneca’s COVID vaccine, a more conventional type than Pfizer’s or Moderna’s, has been the subject of significant controversy in recent weeks over concerns over data in the company’s efficacy studies and bungled communication with regulators. Still, they are being deployed internationally (though not yet in the U.S.)

In clinical trials, doses of AstraZeneca’s vaccine were originally scheduled 4 to 12 weeks apart across various studies. But during the rollout, recommended waits between doses have varied by country.

For instance, the U.K. implemented a 12-week gap between the two doses in the AstraZeneca regimen, instigating a major scientific debate. It’s a balance between managing the supply of available doses, which have been administered to narrower swaths of the population than in the U.S., and sussing out whether or not such a long delay helps or hurts building up the immune response to COVID.

In other European nations, such as Italy and Germany, the gap between doses may be even greater. As the continent struggles with a supply chain dilemma, some providers have pointed to studies suggesting that a longer wait between the two doses may be beneficial, and others have flagged research suggesting that a single dose may be enough for those who had been infected with COVID-19 up to six months before getting their first shot.

A pooled analysis published in the journal Lancet in late February suggests there isn’t much of a deleterious effect on COVID antibodies with a longer gap between the first and the booster dose of AstraZeneca’s vaccine, with preliminary evidence suggesting it actually may be a more effective biological strategy than a shorter time between shots.

More information will clearly be coming in on this issue via ongoing studies. But regardless of which vaccine you’re getting, Pfizer’s, Moderna’s, Johnson & Johnson’s, or AstraZeneca’s, consult with your physician on the dosing timeline, since it can be so variable. And be prepared to wait up to several months before all those COVID antibodies form.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

CDC to escalate Ebola response after WHO declares emergency
HealthHealth
CDC to escalate Ebola response after WHO declares emergency
By Jessica Nix and BloombergMay 17, 2026
19 hours ago
WHO declares latest Ebola outbreak a global health emergency. A rare variant of the disease with no approved treatments is to blame
HealthHealth
WHO declares latest Ebola outbreak a global health emergency. A rare variant of the disease with no approved treatments is to blame
By Chinedu Asadu and The Associated PressMay 17, 2026
1 day ago
hoeg
HealthFDA
RFK ally confirms she was fired by FDA: ‘I learned so much and leave with no regrets’
By Matthew Perrone and The Associated PressMay 16, 2026
2 days ago
lawyer
CommentaryLaw
Would you hire the lawyer who just got sanctioned for using AI?
By Alexandra SmythMay 16, 2026
2 days ago
lori
Commentarymental health
I run Valvoline Instant Oil Change and work with young people every day. They’re in crisis—and we all have to try to help
By Lori FleesMay 15, 2026
3 days ago
Claude is telling users to go to sleep mid-session and nobody, including Anthropic, seems to fully understand why it keeps doing it
AITech
Claude is telling users to go to sleep mid-session and nobody, including Anthropic, seems to fully understand why it keeps doing it
By Marco Quiroz-GutierrezMay 14, 2026
4 days ago

Most Popular

The top foreign holders of U.S. debt may soon dump Treasury bonds and bring their money back home, potentially spiking borrowing costs
Economy
The top foreign holders of U.S. debt may soon dump Treasury bonds and bring their money back home, potentially spiking borrowing costs
By Jason MaMay 17, 2026
1 day ago
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI
AI
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI
By Jake AngeloMay 16, 2026
2 days ago
The Bezos family just donated $100 million to help achieve one of Mayor Zohran Mamdani’s top campaign promises
Politics
The Bezos family just donated $100 million to help achieve one of Mayor Zohran Mamdani’s top campaign promises
By Jake AngeloMay 12, 2026
6 days ago
'No one was coming to save me': How Reese Witherspoon built a $900 million company from a problem Hollywood wouldn't fix
Success
'No one was coming to save me': How Reese Witherspoon built a $900 million company from a problem Hollywood wouldn't fix
By Sydney LakeMay 17, 2026
1 day ago
SpaceX heads into a record-shattering IPO with the 'deepest moat that exists today' as investors vow to 'never bet against Elon'
Innovation
SpaceX heads into a record-shattering IPO with the 'deepest moat that exists today' as investors vow to 'never bet against Elon'
By Jason MaMay 16, 2026
2 days ago
Gen X is the most indebted generation in America. Their employers can fix that
Commentary
Gen X is the most indebted generation in America. Their employers can fix that
By Mary MorelandMay 17, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.